These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33547634)

  • 41. Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells.
    Belnoue E; Fontannaz-Bozzotti P; Grillet S; Lambert PH; Siegrist CA
    J Virol; 2007 Jul; 81(14):7338-50. PubMed ID: 17494081
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polymicrobial Sepsis Increases Susceptibility to Chronic Viral Infection and Exacerbates CD8+ T Cell Exhaustion.
    Condotta SA; Khan SH; Rai D; Griffith TS; Badovinac VP
    J Immunol; 2015 Jul; 195(1):116-25. PubMed ID: 25980007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of Resistance to Mousepox during Chronic Lymphocytic Choriomeningitis Virus Infection Is Associated with Impaired T-Cell Responses and Can Be Rescued by Immunization.
    Alves-Peixoto P; Férez M; Knudson CJ; Melo-Silva CR; Stotesbury C; Wong EB; Correia-Neves M; Sigal LJ
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adenovirus Vector Vaccination Impacts NK Cell Rheostat Function following Lymphocytic Choriomeningitis Virus Infection.
    Blass E; Aid M; Martinot AJ; Larocca RA; Kang ZH; Badamchi-Zadeh A; Penaloza-MacMaster P; Reeves RK; Barouch DH
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514912
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD8 T cell responses to lymphocytic choriomeningitis virus in early growth response gene 1-deficient mice.
    Singh A; Svaren J; Grayson J; Suresh M
    J Immunol; 2004 Sep; 173(6):3855-62. PubMed ID: 15356133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection.
    Zhou S; Cerny AM; Fitzgerald KA; Kurt-Jones EA; Finberg RW
    J Virol; 2012 Oct; 86(20):11254-65. PubMed ID: 22875973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An MHC class Ib-restricted CD8+ T cell response to lymphocytic choriomeningitis virus.
    Chen L; Jay DC; Fairbanks JD; He X; Jensen PE
    J Immunol; 2011 Dec; 187(12):6463-72. PubMed ID: 22084437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus.
    Yanagi Y; Maekawa R; Cook T; Kanagawa O; Oldstone MB
    J Virol; 1990 Dec; 64(12):5919-26. PubMed ID: 1700830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection.
    Crosby EJ; Goldschmidt MH; Wherry EJ; Scott P
    PLoS Pathog; 2014 Feb; 10(2):e1003970. PubMed ID: 24586170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NK cell-intrinsic FcεRIγ limits CD8+ T-cell expansion and thereby turns an acute into a chronic viral infection.
    Duhan V; Hamdan TA; Xu HC; Shinde P; Bhat H; Li F; Al-Matary Y; Häussinger D; Bezgovsek J; Friedrich SK; Hardt C; Lang PA; Lang KS
    PLoS Pathog; 2019 Jun; 15(6):e1007797. PubMed ID: 31220194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD8
    Snell LM; MacLeod BL; Law JC; Osokine I; Elsaesser HJ; Hezaveh K; Dickson RJ; Gavin MA; Guidos CJ; McGaha TL; Brooks DG
    Immunity; 2018 Oct; 49(4):678-694.e5. PubMed ID: 30314757
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel Lymphocytic Choriomeningitis Virus Strain Sustains Abundant Exhausted Progenitor CD8 T Cells without Systemic Viremia.
    Beura LK; Scott MC; Pierson MJ; Joag V; Wijeyesinghe S; Semler MR; Quarnstrom CF; Busman-Sahay K; Estes JD; Hamilton SE; Vezys V; O'Connor DH; Masopust D
    J Immunol; 2022 Nov; 209(9):1691-1702. PubMed ID: 36122933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vectored antibody gene delivery restores host B and T cell control of persistent viral infection.
    Ertuna YI; Fallet B; Marx AF; Dimitrova M; Kastner AL; Wagner I; Merkler D; Pinschewer DD
    Cell Rep; 2021 Nov; 37(9):110061. PubMed ID: 34852228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PD-1+ stemlike CD8 T cells are resident in lymphoid tissues during persistent LCMV infection.
    Im SJ; Konieczny BT; Hudson WH; Masopust D; Ahmed R
    Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4292-4299. PubMed ID: 32034098
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus.
    Moskophidis D; Battegay M; van den Broek M; Laine E; Hoffmann-Rohrer U; Zinkernagel RM
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():381-91. PubMed ID: 7531218
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of PKR and Type I IFNs in viral control during primary and secondary infection.
    Nakayama Y; Plisch EH; Sullivan J; Thomas C; Czuprynski CJ; Williams BR; Suresh M
    PLoS Pathog; 2010 Jun; 6(6):e1000966. PubMed ID: 20585572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE.
    Khattar R; Luft O; Yavorska N; Shalev I; Phillips MJ; Adeyi O; Gao D; Bartczak A; Urbanellis P; Shyu W; Zhang J; Manuel J; Levy GA; Selzner N
    PLoS One; 2013; 8(10):e72309. PubMed ID: 24146739
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PSGL-1 Is a T Cell Intrinsic Inhibitor That Regulates Effector and Memory Differentiation and Responses During Viral Infection.
    Tinoco R; Neubert EN; Stairiker CJ; Henriquez ML; Bradley LM
    Front Immunol; 2021; 12():677824. PubMed ID: 34326837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiple layers of CD80/86-dependent costimulatory activity regulate primary, memory, and secondary lymphocytic choriomeningitis virus-specific T cell immunity.
    Eberlein J; Davenport B; Nguyen TT; Victorino F; Sparwasser T; Homann D
    J Virol; 2012 Feb; 86(4):1955-70. PubMed ID: 22156513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization.
    Seiler P; Bründler MA; Zimmermann C; Weibel D; Bruns M; Hengartner H; Zinkernagel RM
    J Exp Med; 1998 Feb; 187(4):649-54. PubMed ID: 9463415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.